Comparison of oncolytic virotherapy and nanotherapy as two new miRNA delivery approaches in lung cancer

Ghorbani Alvanegh, Akbar and Mohammad Ganji, Shahla and kamel, Ali and Tavallaie, Mahmood and Rafati, Alireza and Arpanaei, Ayyoob and Dorostkar, Ruhollah and Esmaeili Gouvarchin Ghaleh, Hadi (2021) Comparison of oncolytic virotherapy and nanotherapy as two new miRNA delivery approaches in lung cancer. Biomedicine & Pharmacotherapy, 140. p. 111755.

Full text not available from this repository.


Lung cancer is known as the second leading cause of cancer death. Finding ways to detect early-stage lung cancer can remarkably increase the survival rate. Biomarkers such as microRNAs can be helpful in cancer diagnosis, predicting its prognosis, and patients' chances of survival. Numerous studies have confirmed the correlation between microRNA expression and the likelihood of patients surviving after treatment. Consequently, it is necessary to study the expression profile of microRNAs during and after treatment. Oncolytic virotherapy and nanotherapy are two neoteric methods that use various vectors to deliver microRNAs into cancer cells. Although these treatments have not yet entered into the clinical trials, much progress has been made in this area. Analyzing the expression profile of microRNAs after applying nanotherapy and oncolytic virotherapy can evaluate the effectiveness of these methods. This review refers to the studies conducted about these two approaches. The advantages and disadvantages of these methods in delivery and affecting microRNA expression patterns are discussed below.

Item Type: Article
Uncontrolled Keywords: miRNAs profile, Oncolytic viruses, Nanoparticle, miRNA delivery, Lung cancer, Oncolytic virotherapy
Subjects: QU Biochemistry > Cell biology and genetics
Divisions: Reserach Vice-Chancellar Department > Cellular and Molecular Research Center
Depositing User: zeynab . bagheri
Date Deposited: 08 Jun 2021 07:29
Last Modified: 08 Jun 2021 07:29

Actions (login required)

View Item View Item